Shalini Sharp - 18 May 2022 Form 4 Insider Report for NEUROCRINE BIOSCIENCES INC (NBIX)

Role
Director
Signature
/s/ Darin Lippoldt, Attorney-in-Fact
Issuer symbol
NBIX
Transactions as of
18 May 2022
Net transactions value
$0
Form type
4
Filing time
20 May 2022, 16:16:10 UTC
Previous filing
18 Jan 2022
Next filing
08 Jun 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NBIX Non-Qualified Stock Option Award $0 +9,724 $0.000000 9,724 18 May 2022 Common Stock 9,724 $84.95 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Option vests in 12 monthly installments beginning June 18, 2022.